EDGAR Filing Documents for 0001144204-14-052197

Form 8-K - Current report:

SEC Accession No. 0001144204-14-052197

Filing Date

2014-08-25

Accepted

2014-08-25 08:04:41

Documents

Period of Report

2014-08-25

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v387623_8k.htm	8-K	15522
2	EXHIBIT 99.1	v387623_ex99-1.htm	EX-99.1	9523
	Complete submission text file	0001144204-14-052197.txt		26226

Mailing Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000

Business Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000 353971536401

Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)